You have 9 free searches left this month | for more free features.

Lymphocytosis

Showing 1 - 25 of 245

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

Not yet recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Ibrutinib 420 mg
  • (no location specified)
Jan 12, 2023

Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

Not yet recruiting
  • Lymphoproliferative Disorders
  • +3 more
  • No intervention
  • (no location specified)
Jan 30, 2023

Agricultural Health Study Cohort Pesticide Exposure Study

Completed
  • Multiple Myeloma
  • +3 more
    • Iowa City, Iowa
    • +1 more
    Jan 25, 2023

    Commercially Available Vaccines Against SARS-CoV-2 in

    Recruiting
    • Monoclonal B-Cell Lymphocytosis
    • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Feb 10, 2022

      Aplastic Anemia, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Ibrutinib)

      Active, not recruiting
      • Aplastic Anemia
      • +6 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 24, 2022

      Family Study of Lymphoproliferative Disorders

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +4 more
        • Rochester, Minnesota
          Mayo Clinic
        Aug 30, 2021

        Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

        Enrolling by invitation
        • Monoclonal Gammopathy of Undetermined Significance
        • +6 more
          • Milwaukee, Wisconsin
            Aurora Health Care
          Jul 20, 2021

          Monoclonal B-Cell Lymphocytosis, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in Scottsdale,

          Terminated
          • Monoclonal B-Cell Lymphocytosis
          • +3 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Scottsdale, Arizona
          • +2 more
          Jan 15, 2021

          Study on the Diagnosis and Management of CLL in Italy by GIMEMA

          Recruiting
          • Chronic Lymphocytic Leukemia
          • +2 more
            • Alessandria, Italy
            • +17 more
            Jan 3, 2022

            Kinetics of Lymphoid Cells in Monoclonal B-cell Lymphocytosis,

            Completed
            • Lymphoma, Mantle-cell
            • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jul 13, 2020

              Baby Detect : Genomic Newborn Screening

              Recruiting
              • Congenital Adrenal Hyperplasia
              • +126 more
                • Liege, Wallonia, Belgium
                  CRMN, Hôpital La Citadelle
                Jan 24, 2023

                Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection

                Active, not recruiting
                • Bone Marrow Failure Syndrome
                • +15 more
                • CD34 Stem Cell Selection Therapy
                • New York, New York
                  Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
                Jun 17, 2020

                Anemia, Cancer Fatigue, Chronic Lymphocytic Leukemia Trial in Houston (Ex Vivo-activated Autologous Lymph Node Lymphocytes,

                Completed
                • Anemia
                • +13 more
                • Ex Vivo-activated Autologous Lymph Node Lymphocytes
                • Laboratory Biomarker Analysis
                • Houston, Texas
                  M D Anderson Cancer Center
                Oct 7, 2019

                Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom

                Recruiting
                • Chronic Lymphocytic Leukemia, CLL
                • Aylesbury, United Kingdom
                • +7 more
                Jan 12, 2023

                Orelabrutinib in the Treatment of CLL/SLL

                Not yet recruiting
                • CLL/SLL
                  • (no location specified)
                  Jul 26, 2023

                  Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

                  Completed
                  • Chronic Lymphocytic Leukemia
                  • +9 more
                  • Houston, Texas
                    M D Anderson Cancer Center
                  Apr 16, 2019

                  Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Obinutuzumab)

                  Recruiting
                  • Lymphoma, Non-Hodgkin
                  • Boston, Massachusetts
                  • +17 more
                  Aug 1, 2022

                  Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

                  Terminated
                  • Small Lymphocytic Leukemia (SLL)
                  • Chronic Lymphocytic Leukemia (CLL)
                  • Bethesda, Maryland
                    National Institutes of Health Clinical Center
                  Feb 15, 2022

                  Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Germany (Obinutuzumab)

                  Terminated
                  • Chronic Lymphocytic Leukemia
                  • Richter's Transformation
                  • Obinutuzumab
                  • Bonn, Germany
                  • +6 more
                  Dec 16, 2021

                  Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)

                  Active, not recruiting
                  • Chronic Lymphocytic Leukemia
                  • Small Lymphocytic Lymphoma
                  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
                  • +6 more
                  • Columbus, Ohio
                    Ohio State University Comprehensive Cancer Center
                  Feb 24, 2022

                  Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

                  Active, not recruiting
                  • Leukemia, Lymphoid
                  • +6 more
                  • Wuhu, Anhui, China
                  • +22 more
                  Dec 8, 2022

                  Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

                  Completed
                  • Leukemia, Lymphocytic, Chronic
                  • Dresden, Germany
                  • +10 more
                  Jan 13, 2023

                  CLL/SLL Trial in China (ICP-022)

                  Active, not recruiting
                  • CLL/SLL
                  • Hefei, Anhui, China
                  • +24 more
                  Jul 5, 2022

                  CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

                  Not yet recruiting
                  • CLL
                  • (no location specified)
                  Oct 3, 2023